X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Merck Ltd with Torrent Pharma - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

MERCK LTD vs TORRENT PHARMA - Comparison Results

MERCK LTD    Change

Merck, the Indian arm of Merck KgaA (Germany), is a relatively smaller player among MNC pharma majors in the country. Merck has two business segments namely Pharmaceuticals and Chemicals. The pharmaceutical business, accounting for 68% of total sales... More

TORRENT PHARMA 
   Change

Torrent Pharmaceuticals Ltd. is the flagship company of the Torrent Group set up in 1959. Based in Ahmedabad, it was promoted by Mr U.N. Mehta initially as Trinity Laboratories Ltd. and was later renamed to its current name. The company derives its r... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    MERCK LTD TORRENT PHARMA MERCK LTD/
TORRENT PHARMA
 
P/E (TTM) x 34.2 27.2 125.3% View Chart
P/BV x 3.8 5.2 73.8% View Chart
Dividend Yield % 0.7 1.1 70.4%  

Financials

 MERCK LTD   TORRENT PHARMA
EQUITY SHARE DATA
    MERCK LTD
Dec-16
TORRENT PHARMA
Mar-17
MERCK LTD/
TORRENT PHARMA
5-Yr Chart
Click to enlarge
High Rs1,0601,768 60.0%   
Low Rs6231,186 52.5%   
Sales per share (Unadj.) Rs632.4346.1 182.7%  
Earnings per share (Unadj.) Rs45.755.2 82.9%  
Cash flow per share (Unadj.) Rs62.373.3 85.0%  
Dividends per share (Unadj.) Rs11.0014.00 78.6%  
Dividend yield (eoy) %1.30.9 137.9%  
Book value per share (Unadj.) Rs388.8257.1 151.3%  
Shares outstanding (eoy) m16.60169.22 9.8%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.34.3 31.2%   
Avg P/E ratio x18.426.8 68.8%  
P/CF ratio (eoy) x13.520.1 67.0%  
Price / Book Value ratio x2.25.7 37.7%  
Dividend payout %24.125.4 94.8%   
Avg Mkt Cap Rs m13,969249,887 5.6%   
No. of employees `0001.611.8 13.4%   
Total wages/salary Rs m1,4879,934 15.0%   
Avg. sales/employee Rs Th6,631.94,971.5 133.4%   
Avg. wages/employee Rs Th939.2843.2 111.4%   
Avg. net profit/employee Rs Th479.4792.4 60.5%   
INCOME DATA
Net Sales Rs m10,49858,569 17.9%  
Other income Rs m2422,233 10.9%   
Total revenues Rs m10,74160,802 17.7%   
Gross profit Rs m1,13513,773 8.2%  
Depreciation Rs m2763,069 9.0%   
Interest Rs m02,056 0.0%   
Profit before tax Rs m1,10210,881 10.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m3431,545 22.2%   
Profit after tax Rs m7599,336 8.1%  
Gross profit margin %10.823.5 46.0%  
Effective tax rate %31.114.2 219.3%   
Net profit margin %7.215.9 45.4%  
BALANCE SHEET DATA
Current assets Rs m6,41053,841 11.9%   
Current liabilities Rs m8,82831,612 27.9%   
Net working cap to sales %-23.038.0 -60.7%  
Current ratio x0.71.7 42.6%  
Inventory Days Days5897 59.4%  
Debtors Days Days3884 45.8%  
Net fixed assets Rs m1,40642,079 3.3%   
Share capital Rs m166846 19.6%   
"Free" reserves Rs m6,28642,655 14.7%   
Net worth Rs m6,45543,501 14.8%   
Long term debt Rs m022,408 0.0%   
Total assets Rs m8,828101,250 8.7%  
Interest coverage xNM6.3-  
Debt to equity ratio x00.5 0.0%  
Sales to assets ratio x1.20.6 205.6%   
Return on assets %8.611.3 76.4%  
Return on equity %11.821.5 54.8%  
Return on capital %17.119.6 87.0%  
Exports to sales %8.30-   
Imports to sales %21.00-   
Exports (fob) Rs m869NA-   
Imports (cif) Rs m2,209NA-   
Fx inflow Rs m95920,066 4.8%   
Fx outflow Rs m2,6125,304 49.2%   
Net fx Rs m-1,65314,762 -11.2%   
CASH FLOW
From Operations Rs m1,07010,127 10.6%  
From Investments Rs m-750-7,869 9.5%  
From Financial Activity Rs m-150-1,918 7.8%  
Net Cashflow Rs m171212 80.8%  

Share Holding

Indian Promoters % 0.0 71.5 -  
Foreign collaborators % 51.8 0.0 -  
Indian inst/Mut Fund % 18.2 7.0 259.3%  
FIIs % 1.0 12.6 7.9%  
ADR/GDR % 0.0 0.0 -  
Free float % 29.1 8.8 330.7%  
Shareholders   28,591 26,511 107.8%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare MERCK LTD With:   PIRAMAL ENTERPRISES  GSK PHARMA  PANACEA BIOTECH  DR. REDDYS LAB  NOVARTIS  

Compare MERCK LTD With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Global Stock Markets Chart Modest Gains(RoundUp)

Global financial markets ended the holiday shortened week with modest gains. The rally put behind days of decline as concerns regarding swift interest rates hikes were put to ease.

Related Views on News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

The Foundation for Sensex 100,000 is Laid(The 5 Minute Wrapup)

Feb 17, 2018

Top three reasons for Tanushree's presentation at Equitymaster Conference to be centered around a possible 30% correction.

India's Rs 1,66,276 Crore Problem(Vivek Kaul's Diary)

Feb 15, 2018

That's the loss, the government owned public sector enterprises are expected to make this year.

The Big Gamble(The Honest Truth)

Feb 15, 2018

Once you accept the fact that elections are round the corner and that this budget is geared to reach a 40% target, everything makes sense.

How I Beat the Index by 2x... And Why I Believe This Could Happen Again(Smart Contrarian)

Feb 12, 2018

Will Microcap Millionaires be able to replicate its past performance of beating the index by 2x?

NPAs Set to Rise Further with New RBI Rules(Chart Of The Day)

Feb 15, 2018

The RBI overhauls bad loan framework. Banks may come under additional pressure due to rising NPAs and increased provisioning.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

MERCK LTD SHARE PRICE


Feb 23, 2018 (Close)

TRACK MERCK LTD

  • Track your investment in MERCK LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MERCK LTD 8-QTR ANALYSIS

COMPARE MERCK LTD WITH

MARKET STATS